BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 07:54 pm
Intimation of Trading Window Closure
Fredun Pharmaceuticals Ltd · 539730
✦ AI SummaryRegulatory
Fredun Pharmaceuticals Ltd has announced the closure of the trading window for its designated persons and their immediate relatives from October 1, 2026, until 48 hours after the Board Meeting where the unaudited Financial Results for the quarter and half year ended September 30, 2026, will be considered, approved, and declared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
f5faf2f5-7a6f-407a-80c1-7e5b3f51c09d.pdf
View document text
Date: 28th September, 2026
BSE Ltd.,
Listing Department,
Phiroze Jeejeebhoy Towers,
Dalal Street - Fort,
Mumbai – 400 001
Ref.: BSE Scrip Code - 539730
Subject: Intimation of Closure of Trading Window
Dear Sir / Madam,
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and “Code of
Conduct for Prevention of Insider Trading” of Fredun Pharmaceuticals Limited
(hereinafter referred to as the Company), the trading window for dealing in securities
of the Company will remain closed for designated persons and their immediate
relatives with effect from Thursday, 1st October, 2026 till 48 hours after the end of
the Board Meeting wherein, the approval of unaudited Financial Results for the
quarter and half year ended 30th September, 2026, would be considered, approved
and declared.
The said information is being notified to all designated persons under the above
Regulations.
Kindly take the same on your Records.
Thanking you,
FOR FREDUN PHARMACEUTICALS LIMITED
FREDUN NARIMAN MEDHORA
MANAGING DIRECTOR
DIN: 01745348